AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
DIHYDROERGOKRYPTINE AS LONG-TERM TREATMENT OF ALZHEIMER-TYPE DEMENTIA- A MULTICENTER 2-YEAR FOLLOW-UP
Authors: CUCINOTTA D DELEO D FRATTOLA L TRABUCCHI M ALBIZATTI MG BELTRAMELLI A CIRILLO G FRANCIOSI A GHIRONZI G PALLESCHI M PALUMMERI E PIOLTI R ROMAGNOLI S ROZZINI R SALVIOLI G GIRARDELLO R AMBROSOLI L POLI A PARNETTI L
Citation: D. Cucinotta et al., DIHYDROERGOKRYPTINE AS LONG-TERM TREATMENT OF ALZHEIMER-TYPE DEMENTIA- A MULTICENTER 2-YEAR FOLLOW-UP, Archives of gerontology and geriatrics, 1998, pp. 103-110
IN-VIVO NEUROCHEMICAL CHARACTERISTICS OF NORMAL AND PATHOLOGICAL AGING OF THE BRAIN - ROLE OF MAGNETIC-RESONANCE SPECTROSCOPY
Authors: PARNETTI L TARDUCCI R PALUMBO B PIPPI M MASTRIFORTI R GOBBI G PELLICCIOLI GP
Citation: L. Parnetti et al., IN-VIVO NEUROCHEMICAL CHARACTERISTICS OF NORMAL AND PATHOLOGICAL AGING OF THE BRAIN - ROLE OF MAGNETIC-RESONANCE SPECTROSCOPY, Archives of gerontology and geriatrics, 1998, pp. 393-398
CEREBROSPINAL-FLUID PYRUVATE LEVELS IN ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA
Authors: PARNETTI L GAITI A CADINI D MASTRIFORTI R CHIONNE F GALLAI V
Citation: L. Parnetti et al., CEREBROSPINAL-FLUID PYRUVATE LEVELS IN ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA, Neurology, 50(4), 1998, pp. 6112-6112
ROLE OF HOMOCYSTEINE IN AGE-RELATED VASCULAR AND NONVASCULAR DISEASES
Authors: PARNETTI L BOTTIGLIERI T LOWENTHAL D
Citation: L. Parnetti et al., ROLE OF HOMOCYSTEINE IN AGE-RELATED VASCULAR AND NONVASCULAR DISEASES, Aging, 9(4), 1997, pp. 241-257
APOLIPOPROTEIN-E GENOTYPE IN NORMAL AGING, AGE-ASSOCIATED MEMORY IMPAIRMENT, ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA PATIENTS
Authors: PALUMBO B PARNETTI L NOCENTINI G CARDINALI L BRANCORSINI S RICCARDI C SENIN U
Citation: B. Palumbo et al., APOLIPOPROTEIN-E GENOTYPE IN NORMAL AGING, AGE-ASSOCIATED MEMORY IMPAIRMENT, ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA PATIENTS, Neuroscience letters, 231(1), 1997, pp. 59-61
DIAGNOSING ALZHEIMERS-DISEASE IN VERY ELDERLY PATIENTS - RELEVANCE OFSOME FUNCTIONAL AND PSYCHOBEHAVIORAL ASPECTS ASSESSED BY THE GOTTFRIES-BRANE-STEEN RATING-SCALE FOR DEMENTIA
Authors: PARNETTI L BROOKS JO PIPPI M CAPUTO N CHIONNE F SENIN U ABATE G PENNESE F PALOMBO V SCURTI R AZZINI C OLIANI G SANGIORGI GB GIORDANO M BARTORELLI L MONINI P MARTINI T TOGNETTI A BONAIUTO S CUCINOTTA D MARINI G TUPONE M ROSSI S CUZZUPOLI M MANSOLDO G POSTIGLIONE A MILAN G SORICELLI A SCALI G SCALISI P MARINELLI MA MANCINELLI MD MECOCCI P VILLARDITA C LOMEO C
Citation: L. Parnetti et al., DIAGNOSING ALZHEIMERS-DISEASE IN VERY ELDERLY PATIENTS - RELEVANCE OFSOME FUNCTIONAL AND PSYCHOBEHAVIORAL ASPECTS ASSESSED BY THE GOTTFRIES-BRANE-STEEN RATING-SCALE FOR DEMENTIA, Gerontology, 43(6), 1997, pp. 335-342
COMPLEMENT AND CONTACT SYSTEM ACTIVATION IN ALZHEIMERS-DISEASE
Authors: BERGAMASCHINI L CANZIANI S CUGNO M PARNETTI L AGOSTONI A
Citation: L. Bergamaschini et al., COMPLEMENT AND CONTACT SYSTEM ACTIVATION IN ALZHEIMERS-DISEASE, Journal of allergy and clinical immunology, 99(1), 1997, pp. 112-112
VASCULAR DEMENTIA ITALIAN SULODEXIDE STUDY (VADISS) - CLINICAL AND BIOLOGICAL RESULTS
Authors: PARNETTI L MARI D ABATE G BALESTRERI R CUCINOTTA D COPPOLA R CHERUBINI A FERRARI P SENIN U
Citation: L. Parnetti et al., VASCULAR DEMENTIA ITALIAN SULODEXIDE STUDY (VADISS) - CLINICAL AND BIOLOGICAL RESULTS, Thrombosis research, 87(2), 1997, pp. 225-233
PROTON MAGNETIC-RESONANCE SPECTROSCOPY CAN DIFFERENTIATE ALZHEIMERS-DISEASE FROM NORMAL AGING
Authors: PARNETTI L TARDUCCI R PRESCIUTTI O LOWENTHAL DT PIPPI M PALUMBO B GOBBI G PELLICCIOLI GP SENIN U
Citation: L. Parnetti et al., PROTON MAGNETIC-RESONANCE SPECTROSCOPY CAN DIFFERENTIATE ALZHEIMERS-DISEASE FROM NORMAL AGING, Mechanism of ageing and development, 97(1), 1997, pp. 9-14
COGNITIVE ENHANCEMENT THERAPY FOR ALZHEIMERS-DISEASE - THE WAY FORWARD
Authors: PARNETTI L SENIN U MECOCCI P
Citation: L. Parnetti et al., COGNITIVE ENHANCEMENT THERAPY FOR ALZHEIMERS-DISEASE - THE WAY FORWARD, Drugs, 53(5), 1997, pp. 752-768
HEMOSTASIS ABNORMALITIES IN PATIENTS WITH VASCULAR DEMENTIA AND ALZHEIMERS-DISEASE
Authors: MARI D PARNETTI L COPPOLA R BOTTASSO B REBOLDI GP SENIN U MANNUCCI PM
Citation: D. Mari et al., HEMOSTASIS ABNORMALITIES IN PATIENTS WITH VASCULAR DEMENTIA AND ALZHEIMERS-DISEASE, Thrombosis and haemostasis, 75(2), 1996, pp. 216-218
DIHYDROERGOKRYPTINE VS PLACEBO IN DEMENTIA OF ALZHEIMER-TYPE - INTERIM RESULTS OF A RANDOMIZED MULTICENTER STUDY AFTER A 1-YEAR FOLLOW-UP
Authors: CUCINOTTA D DELEO D FRATTOLA L TRABUCCHI M PARNETTI L
Citation: D. Cucinotta et al., DIHYDROERGOKRYPTINE VS PLACEBO IN DEMENTIA OF ALZHEIMER-TYPE - INTERIM RESULTS OF A RANDOMIZED MULTICENTER STUDY AFTER A 1-YEAR FOLLOW-UP, Archives of gerontology and geriatrics, 22(2), 1996, pp. 169-180
PHARMACOKINETIC PROFILE AND ENDOCRINE EFFECTS OF POSATIRELIN TREATMENT IN HEALTHY ELDERLY SUBJECTS
Authors: REBOLDI G PARNETTI L SANTEUSANIO F AMBROSOLI L PALUMBO B CHERUBINI A GIRARDELLO R POLI A LOWENTHAL DT SENIN U
Citation: G. Reboldi et al., PHARMACOKINETIC PROFILE AND ENDOCRINE EFFECTS OF POSATIRELIN TREATMENT IN HEALTHY ELDERLY SUBJECTS, Journal of clinical pharmacology, 36(9), 1996, pp. 823-831
THE MENTAL DETERIORATION BATTERY - NORMATIVE DATA, DIAGNOSTIC RELIABILITY AND QUALITATIVE ANALYSES OF COGNITIVE IMPAIRMENT
Authors: CARLESIMO GA CALTAGIRONE C GAINOTTI G FADDA L GALLASSI R LORUSSO S MARFIA G MARRA C NOCENTINI U PARNETTI L
Citation: Ga. Carlesimo et al., THE MENTAL DETERIORATION BATTERY - NORMATIVE DATA, DIAGNOSTIC RELIABILITY AND QUALITATIVE ANALYSES OF COGNITIVE IMPAIRMENT, European neurology, 36(6), 1996, pp. 378-384
H-1-MRS, MRI-BASED HIPPOCAMPAL VOLUMETRY, AND TC-99M-HMPAO-SPECT IN NORMAL AGING, AGE-ASSOCIATED MEMORY IMPAIRMENT, AND PROBABLE ALZHEIMERS-DISEASE
Authors: PARNETTI L LOWENTHAL DT PRESCIUTTI O PELLICCIOLI GP PALUMBO R GOBBI G CHIARINI P PALUMBO B TARDUCCI R SENIN U
Citation: L. Parnetti et al., H-1-MRS, MRI-BASED HIPPOCAMPAL VOLUMETRY, AND TC-99M-HMPAO-SPECT IN NORMAL AGING, AGE-ASSOCIATED MEMORY IMPAIRMENT, AND PROBABLE ALZHEIMERS-DISEASE, Journal of the American Geriatrics Society, 44(2), 1996, pp. 133-138
POSATIRELIN IN THE TREATMENT OF VASCULAR DEMENTIA - A DOUBLE-BLIND MULTICENTER STUDY VS PLACEBO
Authors: PARNETTI L AMBROSOLI L AGLIATI G CARATOZZOLO P FOSSATI L FRATTOLA L MARTUCCI N MURRI L NAPPI G PUCA FM POLI A GIRARDELLO R SENIN U
Citation: L. Parnetti et al., POSATIRELIN IN THE TREATMENT OF VASCULAR DEMENTIA - A DOUBLE-BLIND MULTICENTER STUDY VS PLACEBO, Acta neurologica Scandinavica, 93(6), 1996, pp. 456-463
RELEVANCE OF AGING IN CAROTID DISEASE - RESULTS OF A POPULATION SURVEY
Authors: PARNETTI L SANTUCCI A MENCULINI G CHERUBINI A SENIN U
Citation: L. Parnetti et al., RELEVANCE OF AGING IN CAROTID DISEASE - RESULTS OF A POPULATION SURVEY, Cerebrovascular diseases, 5(6), 1995, pp. 386-390
ACUTE-PHASE REACTANT ALPHA(1)-ANTICHYMOTRYPSIN IS INCREASED IN CEREBROSPINAL-FLUID AND SERUM OF PATIENTS WITH PROBABLE ALZHEIMER-DISEASE
Authors: LICASTRO F PARNETTI L MORINI MC DAVIS LJ CUCINOTTA D GAITI A SENIN U
Citation: F. Licastro et al., ACUTE-PHASE REACTANT ALPHA(1)-ANTICHYMOTRYPSIN IS INCREASED IN CEREBROSPINAL-FLUID AND SERUM OF PATIENTS WITH PROBABLE ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 9(2), 1995, pp. 112-118
CLINICAL PHARMACOKINETICS OF DRUGS FOR ALZHEIMERS-DISEASE
Authors: PARNETTI L
Citation: L. Parnetti, CLINICAL PHARMACOKINETICS OF DRUGS FOR ALZHEIMERS-DISEASE, Clinical pharmacokinetics, 29(2), 1995, pp. 110-129
INCREASED CEREBROSPINAL-FLUID PYRUVATE LEVELS IN ALZHEIMERS-DISEASE
Authors: PARNETTI L GAITI A POLIDORI MC BRUNETTI M PALUMBO B CHIONNE F CADINI D CECCHETTI R SENIN U
Citation: L. Parnetti et al., INCREASED CEREBROSPINAL-FLUID PYRUVATE LEVELS IN ALZHEIMERS-DISEASE, Neuroscience letters, 199(3), 1995, pp. 231-233
CEREBROSPINAL-FLUID NEURON-SPECIFIC ENOLASE IN ALZHEIMERS-DISEASE ANDVASCULAR DEMENTIA
Authors: PARNETTI L PALUMBO B CARDINALI L LORETI F CHIONNE F CECCHETTI R SENIN U
Citation: L. Parnetti et al., CEREBROSPINAL-FLUID NEURON-SPECIFIC ENOLASE IN ALZHEIMERS-DISEASE ANDVASCULAR DEMENTIA, Neuroscience letters, 183(1-2), 1995, pp. 43-45
GLYCOSAMINOGLYCAN POLYSULFATE IN PRIMARY DEGENERATIVE DEMENTIA - PILOT-STUDY OF BIOLOGIC AND CLINICAL EFFECTS
Authors: PARNETTI L BAN TA SENIN T
Citation: L. Parnetti et al., GLYCOSAMINOGLYCAN POLYSULFATE IN PRIMARY DEGENERATIVE DEMENTIA - PILOT-STUDY OF BIOLOGIC AND CLINICAL EFFECTS, Neuropsychobiology, 31(2), 1995, pp. 76-80
DEXAMETHASONE SUPPRESSION TEST IN ELDERLY PATIENTS WITH DEMENTIA OF ALZHEIMER-TYPE, VASCULAR DEMENTIA AND STROKE - A REEVALUATION OF ITS APPLICABILITY
Authors: PARNETTI L REBOLDI G SANTUCCI C PALUMBO B CARDINALI L SANTEUSANIO F CECCHETTI R SENIN U
Citation: L. Parnetti et al., DEXAMETHASONE SUPPRESSION TEST IN ELDERLY PATIENTS WITH DEMENTIA OF ALZHEIMER-TYPE, VASCULAR DEMENTIA AND STROKE - A REEVALUATION OF ITS APPLICABILITY, Archives of gerontology and geriatrics, 21(2), 1995, pp. 205-214
SERUM ANTI-GFAP AND ANTI-S100 AUTOANTIBODIES IN BRAIN AGING, ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA
Authors: MECOCCI P PARNETTI L ROMANO G SCARELLI A CHIONNE F CECCHETTI R POLIDORI MC PALUMBO B CHERUBINI A SENIN U
Citation: P. Mecocci et al., SERUM ANTI-GFAP AND ANTI-S100 AUTOANTIBODIES IN BRAIN AGING, ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA, Journal of neuroimmunology, 57(1-2), 1995, pp. 165-170
INCREASED CSF PYRUVATE LEVELS AS A MARKER OF IMPAIRED ENERGY-METABOLISM IN ALZHEIMERS-DISEASE
Authors: PARNETTI L GAITI A BRUNETTI M AVELLINI L POLIDORI C CECCHETTI R PALUMBO B SENIN U
Citation: L. Parnetti et al., INCREASED CSF PYRUVATE LEVELS AS A MARKER OF IMPAIRED ENERGY-METABOLISM IN ALZHEIMERS-DISEASE, Journal of the American Geriatrics Society, 43(3), 1995, pp. 316-318
Risultati: 1-25 | 26-36